SPI Premium Insight: Doctolib’s €92M Mission to Disrupt

French health IT developer Doctolib has unveiled plans to invest €92M this year on ‘innovation’. It is another statement of intent from a company which has, in just a few years, become a household name to hundreds of thousands of GPs, and millions of patients, in its home country. 

According to the company, the investment will focus on developing solutions and strategies around seven key themes. This includes a tool to help tackle the problem of missed appointments for patients with chronic conditions, and new software allowing it to serve new healthcare specialisms.